Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Surrozen, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +1 vs. Q1 2025
- Shares held
- 6.03M
- +581.7K (+10.7%) vs. Q1 2025
- Total value
- $53.9M
- −$9.62M (−15.1%) vs. Q1 2025
- New holders
- 3
- 8 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 52 | $465 | 0.00% | +36+225.0% | Added |
| Tower Research Capital LLC (TRC) | 216 | $1.93K | 0.00% | −186−46.3% | Reduced |
| UBS Group AG | 259 | $2.31K | 0.00% | +62+31.5% | Added |
| Wolverine Asset Management LLC | 281 | $2.51K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 10,188 | $91.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,451 | $93.4K | 0.00% | +10,451 | New |
| Renaissance Technologies LLC | 14,626 | $130.8K | 0.00% | +400+2.8% | Added |
| BlackRock, Inc. | 15,483 | $138.4K | 0.00% | +7,163+86.1% | Added |
| Price T Rowe Associates Inc | 21,715 | $195.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 30,963 | $276.9K | 0.00% | +5,702+22.6% | Added |
| Morgan Stanley | 34,764 | $310.8K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 47,930 | $428.5K | 0.06% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 52,130 | $466.0K | 0.05% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 55,123 | $492.8K | 0.01% | 00.0% | Unchanged |
| Armistice Capital, LLC | 60,000 | $536.4K | 0.02% | +60,000 | New |
| Driehaus Capital Management LLC | 67,566 | $604.0K | 0.00% | −137,368−67.0% | Reduced |
| Euclidean Capital LLC | 87,696 | $784.0K | 0.26% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 88,653 | $792.6K | 0.00% | 00.0% | Unchanged |
| Regents of the University of California | 133,207 | $1.19M | 0.10% | 00.0% | Unchanged |
| Braidwell LP | 140,000 | $1.25M | 0.04% | +140,000 | New |
| Acuta Capital Partners, LLC | 170,000 | $1.52M | 2.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 218,950 | $1.96M | 0.00% | +150,924+221.9% | Added |
| Nantahala Capital Management, LLC | 229,527 | $2.05M | 0.15% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 241,400 | $2.16M | 0.44% | 00.0% | Unchanged |
| Vivo Capital, LLC | 260,000 | $2.32M | 0.24% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 306,029 | $2.74M | 2.70% | +20,247+7.1% | Added |
| 5AM Venture Management, LLC | 310,000 | $2.77M | 1.07% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 602,626 | $5.39M | 0.09% | −76,504−11.3% | Reduced |
| VR Adviser, LLC | 632,931 | $5.66M | 0.42% | 00.0% | Unchanged |
| StemPoint Capital LP | 686,539 | $6.14M | 1.98% | +445,713+185.1% | Added |
| The Column Group LLC | 1,499,773 | $13.4M | 20.40% | 00.0% | Unchanged |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −44,978−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |